Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 420 Lexington Ave, Suite 414 NEW YORK NY 10170 |
Tel: | N/A |
Website: | https://www.ianthus.com |
IR: | See website |
Key People | ||
Richard Proud Chief Executive Officer, Director | Justin Vu Interim Chief Financial Officer |
Business Overview |
iAnthus Capital Holdings, Inc. is a vertically integrated, multi-state owner and operator of licensed cannabis cultivation, processing, and dispensary facilities. The Company is also a developer, producer, and distributor of branded cannabis and cannabidiol (CBD) products in the United States. Through its subsidiaries, the Company owns and/or operates 37 dispensaries and eight cultivation and/or processing facilities in seven United States. Its multi-state operations encompass a full range of medical and adult-use cannabis enterprises, including cultivation, processing, product development, wholesale-distribution, and retail. The Company offers various cannabis products, which includes flower and trim, products containing cannabis flower and trim, such as packaged flower and pre-rolls; cannabis infused products, such as topical creams and edibles and products containing cannabis extracts, such as vape cartridges, concentrates, live resins, wax products, oils, and tinctures. |
Financial Overview |
For the six months ended 30 June 2024, iAnthus Capital Holdings Inc revenues increased 12% to $84.6M. Net loss decreased 39% to $23.8M. Revenues reflect Eastern Region segment increase of 34% to $62.6M. Lower net loss reflects Interest and other income increase from $877K to $3.4M (income), Salaries and employee benefits decrease of 14% to $13.7M (expense). |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $277.80M as of Jun 30, 2024 |
Annual revenue (TTM): | $234.00M as of Jun 30, 2024 |
EBITDA (TTM): | -$2.05M as of Jun 30, 2024 |
Net annual income (TTM): | -$85.72M as of Jun 30, 2024 |
Free cash flow (TTM): | $7.02M as of Jun 30, 2024 |
Net Debt Last Fiscal Year: | $217.40M as of Jun 30, 2024 |
Shares outstanding: | 6,673,394,942 as of Nov 1, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |